申请人:BOEHRINGER INGELHEIM INT
公开号:WO2020254451A1
公开(公告)日:2020-12-24
The invention describes anti-cancer therapies comprising using a SOS1 inhibitor in combination with a MEK inhibitor, each as described herein.
这项发明描述了抗癌疗法,包括使用SOS1
抑制剂与MEK
抑制剂的组合,如本文所述。